Advertisement

Uric acid: A marker of increased cardiovascular risk

      Abstract

      The relationship between uric acid and cardiovascular disease has been known since the 19th century, after that many authors reported the classical association of gout, hypertension, obesity and cardiovascular disease. With the exception of specific genetic defects in purine metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, insulin resistance, the metabolic syndrome and renal failure. Studies have clearly shown an association between increased uric acid concentrations with oxidative stress, endothelial dysfunction, inflammation, subclinical atherosclerosis and an increased risk of cardiovascular events. Increased uric acid levels are independent markers of cardiovascular disease risk. Prospective studies are necessary to show that reduction of uric acid levels prevent cardiovascular events.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wu X.M.
        • Muzny D.M.
        • Lee C.C.
        • Caskey C.T.
        Two independent mutational events in the loss of urate oxidase during hominoid evolution.
        J Mol Evol. 1992; 34: 78-84
        • Mohamed F.
        On chronic Bright's disease, and essential symptoms.
        Lancet. 1879; 1: 399-401
        • Culleton B.F.
        • Larson M.G.
        • Kannel W.B.
        • Levy D.
        Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.
        Ann Intern Med. 1999; 131: 7-13
        • Choi H.K.
        • Atkinson K.
        • Karlson E.W.
        • Curhan G.
        Obesity, weight change, hypertension, diuretic use and risk of gout in men: the Health Professionals Follow-Up Study.
        Arch Intern Med. 2005; 165: 742-748
        • Johnson R.J.
        • Feig D.I.
        • Herrera-Acosta J.
        • Kang D.H.
        Resurrection of uric acid as a causal risk factor in essential hypertension.
        Hypertension. 2005; 45: 18-20
        • Coutinho T.A.
        • Turner S.T.
        • Peyser P.A.
        • et al.
        Associations of serum uric acid with markers of inflammation, metabolic syndrome and subclinical coronary atherosclerosis.
        Am J Hypertens. 2007; 20: 83-89
        • Ioachimescu A.G.
        • Brennan D.M.
        • Hoar B.M.
        • Hazen S.L.
        • Hoogwerf B.J.
        Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. A preventive cardiology information system (PreCIS) database cohort study.
        Arthritis Rheum. 2008; 58: 623-630
        • Alderman M.H.
        • Cohen H.
        • Madhavan S.
        • Kivlighn S.
        Serum uric acid and cardiovascular events in successfully treated hypertensive patients.
        Hypertension. 1999; 34: 144-150
        • Liese A.D.
        • Hense H.W.
        • Löwel H.
        • et al.
        Association of serum acid with all-cause and cardiovascular disease and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases.
        Epidemiology. 1999; 10: 391-397
        • Bos M.J.
        • Koudstaal P.J.
        • Hofman A.
        • Witteman J.C.M.
        • Breteker M.M.B.
        Uric acid is a risk factor for myocardial infarction and stroke.
        Stroke. 2006; 37: 1503-1507
        • Moriarity J.T.
        • Folsom A.R.
        • Iribarren C.
        • Nieto F.J.
        • Rosamond W.D.
        Serum acid uric and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) study.
        Ann Epidemiol. 2000; 10: 136-143
        • Hozawa A.
        • Folsom A.R.
        • Ibrahim H.
        • et al.
        Serum uric acid and risk of ischemic stroke: the ARIC study.
        Atherosclerosis. 2006; 187: 401-407
        • Niskanen L.K.
        • Laaksonen D.E.
        • Nyyssönen K.
        • et al.
        Uric acid level as a risk factor for cardiovascular and all-cause morality in middle-aged men: a prospective cohort study.
        Arch Intern Med. 2004; 16: 1546-1551
        • Krishnan E.
        • Baker J.F.
        • Furst D.E.
        • Schumacher H.R.
        Gout and the risk of acute myocardial infarction.
        Arthritis Rheum. 2006; 54: 2688-2696
        • Grundy S.M.
        • et al.
        Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement.
        Circulation. 2005; 112: 2735-2752
        • Schmidt M.I.
        • Duncan B.B.
        • Watson R.L.
        • et al.
        A metabolic syndrome in whites and Áfrican-Americans. The atherosclerosis risk in communities baselines study.
        Diabetes Care. 1996; 19: 414-418
        • Yoo T.W.
        • Sung K.C.
        • Shin H.S.
        • et al.
        Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.
        Circ J. 2005; 69: 928-933
        • Onat A.
        • Uyarel H.
        • Hergenc G.
        • et al.
        Serum uric acid is a determinant of metabolic syndrome in a population-based study.
        Am J Hypertens. 2006; 19: 1055-1062
        • Tuttle K.R.
        • Short R.A.
        • Johnson R.J.
        Sex differences in uric acid and risk factors for coronary artery disease.
        Am J Cardiol. 2001; 87: 1411-1414
        • Chien K.L.
        • Hsu H.C.
        • Sung F.C.
        • Chen M.F.
        • Lee Y.T.
        Hyperuricemia as risk factor on cardiovascular events in Taiwan: the Chin-Shan Community Cardiovascular Cohort study.
        Atherosclerosis. 2005; 183: 147-155
        • Takahashi S.
        • Yamamoto T.
        • Tsutsuni Z.
        • et al.
        Close correlation between visceral fat accumulation and uric acid metabolism in healthy men.
        Metabolism. 1997; 46: 1162-1165
        • Ishizaka N.
        • Ishizaka Y.
        • Ei-Ichi T.
        • Nagai R.
        • Yamakado M.
        Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals.
        Arterioscler Thromb Vasc Biol. 2005; 25: 1038-1044
        • Galvan A.Q.
        • Natali A.
        • Baldi S.
        • et al.
        Effect of insulin on uric acid excretion in humans.
        Am J Physiol. 1995; 268: E1-E5
        • Facchini F.
        • Chen Y.D.
        • Hollenbeck C.B.
        • Reaven G.M.
        Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.
        JAMA. 1991; 26: 1514-1520
        • Lin K.C.
        • Tsao H.M.
        • Chen C.H.
        • Chou P.
        Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
        J Rheumatol. 2004; 31: 1152-1158
        • Verdecchia P.
        • Schillaci G.
        • Reboldi G.
        • et al.
        Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study.
        Hypertension. 2000; 36: 1072-1078
        • Sundström J.
        • Sullivan L.
        • D’Agostino R.
        • et al.
        Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence in the Framingham Heart Study.
        Hypertension. 2005; 45: 28-33
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • et al.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.
        Hypertension. 2003; 416: 1183-1190
        • Giacomello A.
        • Di Sciascio N.
        • Quaratino C.P.
        Relation between serum triglyceride level, serum urate concentration, and fractional urate excretion.
        Metabolism. 1997; 46: 1085-1089
        • Rathman W.
        • Funkhouser E.
        • Dyer A.R.
        • Roseman J.M.
        Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults.
        Ann Epidemiol. 1998; 8: 250-261
        • Desai M.Y.
        • Dalal D.
        • Santos R.D.
        • et al.
        Association of body mass index, metabolic syndrome, and leukocyte count.
        Am J Cardiol. 2005; 97: 835-838
        • Sekby J.V.
        • Friedman G.D.
        • Quesenberry Jr., C.P.
        Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries.
        Am J Epidemiol. 1990; 131: 1017-1027
        • Vourinen-Markkola H.
        • Yki-Jarvinen H.
        Hyperuricemia and insulin resistance.
        J Clin Endocrinol Metab. 1994; 78: 25-29
        • Lee J.
        • Sparrow D.
        • Vokonas P.S.
        • Landsberg L.
        • Weiss S.T.
        Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study.
        Am J Epidemiol. 1995; 142: 288-294
        • McLaughlin T.
        • Abbasi F.
        • Cheal K.
        • et al.
        Use of metabolic markers to identify overweight individuals who are insulin resistant.
        Ann Intern Med. 2003; 139: 802-809
        • Jeppesen J.
        • Hein H.O.
        • Suadicani P.
        • Gyntelberg F.
        Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease.
        Arch Intern Med. 2001; 161: 361-366
        • Messerli F.H.
        • Fröhlich ch E.D.
        • Dreslinski G.R.
        • Suarez D.H.
        • aristimuno G.G.
        Serum uric acid in essential hypertension: an indicator of renal vascular involvement.
        Ann Intern Med. 1980; 93: 817-821
        • Nieto F.J.
        • Iribarren C.
        • Gross M.D.
        • Cosmotock G.W.
        • Cutler R.G.
        Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?.
        Atherosclerosis. 2000; 148: 131-139
        • Tsouli S.G.
        • Liberopoulos E.N.
        • Mikhailidis D.P.
        • Athyros V.G.
        • Elisaf M.S.
        Elevated serum acid levels in metabolic syndrome: an active component or an innocent bystander?.
        Metab Clin Exp. 2006; 55: 1293-1301
        • Ruggiero C.
        • Cherubini A.
        • Ble A.
        • et al.
        Uric acid and inflammatory markers.
        Eur Heart J. 2006; 27: 1174-1181
        • Fröhlich ch M.
        • Imhof A.
        • Berg G.
        • et al.
        Association between C-reactive protein and features of the metabolic syndrome: a population-based study.
        Diabetes Care. 2000; 23: 1835-1839
        • Ruggiero C.
        • Cherubini A.
        • Miller E.
        • et al.
        Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years.
        Am J Cardiol. 2007; 100: 115-121
        • Leyva F.
        • Anker S.D.
        • Godsland I.F.
        • et al.
        Uric acid in chronic heart failure: a marker of chronic inflammation.
        Eur Heart J. 1998; 19: 1814-1822
        • Zweier J.L.
        • Kuppusamy P.
        • Lutty G.A.
        Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.
        Proc Natl Acad Sci USA. 1988; 85: 4046-4050
        • Khosla U.M.
        • Zharikov S.
        • Finch J.L.
        • et al.
        Hyperuricemia induces endothelial dysfunction and vasoconstriction.
        Kidney Int. 2005; 67: 1739-1742
        • Feig D.I.
        • Johnson R.J.
        Hyperuricemia in childhood primary hypertension.
        Hypertension. 2003; 42: 247-252
        • Butler R.
        • Morris A.D.
        • Belch J.J.F.
        • Hill A.
        • Struthers A.D.
        Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.
        Hypertension. 2000; 35: 746-751
        • Farquharson C.A.
        • Butler R.
        • Hill A.
        • Belch J.J.
        • Struthers A.D.
        Allopurinol improves endothelial dysfunction in chronic heart failure.
        Circulation. 2002; 106: 221-226
        • Doehner W.
        • Schoene N.
        • Rauchhaus M.
        • et al.
        Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure.
        Circulation. 2002; 105: 2619-2751
        • Weimert N.A.
        • Tanke W.F.
        • Sims J.J.
        Allopurinol as a cardioprotective during coronary artery bypass graft surgery.
        Ann Pharmacother. 2003; 37: 1708-1711
        • Rumberger J.A.
        • Simons D.B.
        • Fitzpatrick L.A.
        • Sheedy P.F.
        • Schwartz R.S.
        Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study.
        Circulation. 1995; 92: 2157-2162
        • Greenland P.
        • LaBree L.
        • Azen S.P.
        • Doherty T.M.
        • Detrano R.C.
        Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.
        JAMA. 2004; 291: 210-215
        • Arad Y.
        • Goodman K.
        • Roth M.
        • Newstein D.
        • Guerci A.
        Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study.
        J Am Coll Cardiol. 2005; 46: 158-165
        • Santos R.D.
        • Nasir K.
        • Orakzai R.
        • et al.
        Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome.
        Am J Cardiol. 2007; 99: 42-45
        • Santos R.D.
        • Nasir K.
        • Rumberger J.A.
        • et al.
        Difference in atherosclerosis burden in different nations and continents assessed by coronary artery calcium.
        Atherosclerosis. 2006; 187: 378-384
        • Tavil Y.
        • Kaya M.G.
        • Oktar S.Ö.
        • et al.
        Uric acid level and its association with carotid intimal-media thickness in patients with hypertension.
        Atherosclerosis. 2008; 197: 159-163
        • Iribarren C.
        • Folsom A.R.
        • Eckfeldt J.H.
        • McGovern P.G.
        • Nieto F.J.
        Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC study. Atherosclerosis risk in communities.
        Ann Epidemiol. 1996; 6: 331-340
        • Hoieggen A.
        • et al.
        The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
        Kidney Int. 2004; 65: 1041-1049
        • Lehto S.
        • Niskanen L.
        • Ronnemaa T.
        • Laakso M.
        Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
        Stroke. 1998; 29: 635-639
        • Choi H.K.
        • Curhan G.
        Independent impact of gout on mortality and risk for coronary heart disease.
        Circulation. 2007; 116: 894-900
        • Strasak A.
        • Ruttmann E.
        • Brant L.
        • et al.
        Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men.
        Clin Chem. 2008; 54: 273-284
        • Fang J.
        • Alderman M.H.
        Serum acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey.
        JAMA. 2000; 283: 2404-2410